Healthcare -
Biotechnology - NASDAQ - US
$ 57.76
8.14 %
$ 4.33 B
Market Cap
-16.6
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
SpringWorks Therapeutics, Inc.
| Revenue | 192 M |
| Cost Of Revenue | 12.6 M |
| Gross Profit | 179 M |
| Operating Expenses | 457 M |
| Operating Income | -278 M |
| Other Expenses | -20 M |
| Net Income | -258 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Revenue | 191.6 | 5.4 | 6.1 | 0 | 35.0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||||
| Cost Of Revenue | 12.6 | 0.4 | 1.9 | 0.5 | 0.3 | 0.2 | 17.3 K | 3.18 K |
| Gross Profit | 179.0 | 5.0 | 4.3 | (0.5) | 34.7 | (0.2) | 17.3 K | 3.18 K |
| OPERATING INCOME | ||||||||
| Operating Expenses | 457.2 | 348.0 | 280.7 | 173.5 | 81.3 | 59.2 | 18.5 | 4.7 |
| Selling, General and Administrative Expenses | 256.7 | 197.6 | 134.6 | 71.8 | 29.5 | 16.7 | 8.6 | 1.9 |
| Research and Development Expenses | 200.5 | 150.5 | 146.1 | 101.7 | 51.9 | 42.5 | 9.9 | 2.8 |
| Operating Income | (278.1) | (343.0) | (280.7) | (173.5) | (46.3) | (59.2) | (18.5) | (4.7) |
| PRE-TAX INCOME | ||||||||
| Interest Income Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | 20.0 | 17.9 | 3.3 | (0.4) | 0.8 | 0.9 | 0.7 | 21 K |
| Pre-Tax Income | (258.1) | (325.1) | (277.4) | (173.9) | (45.6) | (58.3) | (17.8) | (4.6) |
| NET INCOME | ||||||||
| Tax Provision | 0 | 0 | (3.3) | (0.7) | (1.3) | (3.5) | 0.7 | 2 |
| Net Income | (258.1) | (325.1) | (274.2) | (173.2) | (44.2) | (54.8) | (17.8) | (4.6) |
| EPS | 3.48 | 5.15 | 5.14 | 3.57 | 1.02 | 1.27 | 0.8 | 0.11 |